[HTML][HTML] Obesity-associated improvements in metabolic profile through expansion of adipose tissue

JY Kim, E Van De Wall, M Laplante… - The Journal of …, 2007 - Am Soc Clin Investig
Excess caloric intake can lead to insulin resistance. The underlying reasons are complex but
likely related to ectopic lipid deposition in nonadipose tissue. We hypothesized that the …

Elevated TCA cycle function in the pathology of diet-induced hepatic insulin resistance and fatty liver [S]

S Satapati, NE Sunny, B Kucejova, X Fu, TT He… - Journal of lipid …, 2012 - ASBMB
The manner in which insulin resistance impinges on hepatic mitochondrial function is
complex. Although liver insulin resistance is associated with respiratory dysfunction, the …

Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation

A Purushotham, TT Schug, Q Xu, S Surapureddi, X Guo… - Cell metabolism, 2009 - cell.com
Hepatic metabolic derangements are key components in the development of fatty liver,
insulin resistance, and atherosclerosis. SIRT1, a NAD+-dependent protein deacetylase, is …

LTB4 promotes insulin resistance in obese mice by acting on macrophages, hepatocytes and myocytes

P Li, DY Oh, G Bandyopadhyay, WS Lagakos… - Nature medicine, 2015 - nature.com
Insulin resistance results from several pathophysiologic mechanisms, including chronic
tissue inflammation and defective insulin signaling. We found that liver, muscle and adipose …

Controlled-release mitochondrial protonophore reverses diabetes and steatohepatitis in rats

RJ Perry, D Zhang, XM Zhang, JL Boyer, GI Shulman - Science, 2015 - science.org
Nonalcoholic fatty liver disease (NAFLD) is a major factor in the pathogenesis of type 2
diabetes (T2D) and nonalcoholic steatohepatitis (NASH). The mitochondrial protonophore 2 …

Non-alcoholic fatty liver disease: pathophysiological concepts and treatment options

C Grander, F Grabherr, H Tilg - Cardiovascular Research, 2023 - academic.oup.com
The prevalence of non-alcoholic fatty liver disease (NAFLD) is continually increasing due to
the global obesity epidemic. NAFLD comprises a systemic metabolic disease accompanied …

Disordered lipid metabolism and the pathogenesis of insulin resistance

DB Savage, KF Petersen… - Physiological …, 2007 - journals.physiology.org
Although abnormal glucose metabolism defines type 2 diabetes mellitus (T2DM) and
accounts for many of its symptoms and complications, efforts to understand the …

Overproduction of very low–density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome

M Adiels, SO Olofsson, MR Taskinen… - … , and vascular biology, 2008 - Am Heart Assoc
Insulin resistance is a key feature of the metabolic syndrome and often progresses to type 2
diabetes. Both insulin resistance and type 2 diabetes are characterized by dyslipidemia …

Metabolic inflammation—a role for hepatic inflammatory pathways as drivers of comorbidities in nonalcoholic fatty liver disease?

N Gehrke, JM Schattenberg - Gastroenterology, 2020 - Elsevier
Nonalcoholic fatty liver disease (NAFLD) is a global and growing health concern. Emerging
evidence points toward metabolic inflammation as a key process in the fatty liver that …

Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes

M Ricchi, MR Odoardi, L Carulli… - Journal of …, 2009 - Wiley Online Library
Abstract Background and Aim: Studies have shown monounsaturated oleic acid to be less
toxic than palmitic acid and to prevent/attenuate palmitic acid hepatocites toxicity in steatosis …